Literature DB >> 31748848

Directional X Chromosome Skewing of White Blood Cells from Subjects with Heterozygous Mosaicism for the Variant IRAK1 Haplotype.

Patrick Morcillo1, Yong Qin1, Geber Peña1, Anne C Mosenthal1, David H Livingston1, Zoltan Spolarics2.   

Abstract

Random X chromosome (ChrX) inactivation and consequent cellular mosaicism for the active ChrXs in white blood cells (WBCs) is unique to females and may contribute to sex-biased modulation of the innate immune response. Polymorphic differences between the two parental ChrXs may result in ChrX skewing of circulating WBCs (ChrX inactivation-ratio (XCI) > 3) driven by differences in stem cell selection and activity in the bone marrow or WBC trafficking at the periphery. Independent of the mechanism, ChrX skewing may result in genotype-phenotype discrepancies. This study aimed to develop an allele-specific assay and test its applicability in clinical samples to determine the "direction" of ChrX skewing in the variant IRAK1 haplotype, a common X-linked polymorphism with major clinical impacts. Because alternative splice variants of IRAK1 are also produced in the region surrounding the critical single-nucleotide polymorphism (SNP, rs1059703), we also tested the abundance of alternative splice variant IRAK1 transcripts. The expression of splice variants IRAK1-B and IRAK1-C was about 30 and 50% of the full-length (IRAK1-A) in WBCs from healthy subjects (n = 53). IRAK1-A, B, and C showed about 30% lower expression level in males (n = 25) than females (n = 28). By contrast, the expression levels of IRAK1-A, B, and C were not affected by the variant IRAK1 haplotype in either sex. Allele-specific primers generated WT and variant-IRAK1 amplicons with high selectivity, and on average produced about half the expression levels of each transcript in heterozygous IRAK1-mosaic females. Because injury was shown to induce de novo ChrX skewing of WBCs, we tested the directional XCI ratio changes in WBC in a sample of trauma patients heterozygous for the variant IRAK1 haplotype (n = 18). Using the allele-specific assay in combination with the DNA methylation status at the polymorphic HUMARA locus, we found that at admission, about 60% the patients presented XCI ratios skewed toward WBCs with active ChrXs carrying the variant-IRAK1 similar to healthy controls. De novo, trauma-induced XCI ratio changes showed increased extravasation of the more abundant mosaic WBC subset without reversal in the direction of ChrX skewing during the injury course.

Entities:  

Keywords:  chromosome X; inactivation; inflammation; mosaicism; polymorphism; sex differences; skewing; trauma; variability; white blood cells

Mesh:

Substances:

Year:  2020        PMID: 31748848     DOI: 10.1007/s10753-019-01127-6

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  40 in total

1.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

2.  Hematopoiesis is not clonal in healthy elderly women.

Authors:  Sabina I Swierczek; Neeraj Agarwal; Roberto H Nussenzveig; Gerald Rothstein; Andrew Wilson; Andrew Artz; Josef T Prchal
Journal:  Blood       Date:  2008-07-18       Impact factor: 22.113

Review 3.  X inactivation and reactivation in X-linked diseases.

Authors:  Marcella Vacca; Floriana Della Ragione; Francesco Scalabrì; Maurizio D'Esposito
Journal:  Semin Cell Dev Biol       Date:  2016-03-17       Impact factor: 7.727

4.  IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability.

Authors:  L E Jensen; A S Whitehead
Journal:  J Biol Chem       Date:  2001-06-07       Impact factor: 5.157

Review 5.  Role of base excision repair in maintaining the genetic and epigenetic integrity of CpG sites.

Authors:  Alfonso Bellacosa; Alexander C Drohat
Journal:  DNA Repair (Amst)       Date:  2015-05-01

6.  Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants.

Authors:  Jianmin Su; Kathleen Richter; Chunxiao Zhang; Qiang Gu; Liwu Li
Journal:  Mol Immunol       Date:  2006-05-09       Impact factor: 4.407

7.  X chromosome-linked IRAK-1 polymorphism is a strong predictor of multiple organ failure and mortality postinjury.

Authors:  Jason L Sperry; Samuel Zolin; Brian S Zuckerbraun; Yoram Vodovotz; Rami Namas; Matthew D Neal; Robert E Ferrell; Matthew R Rosengart; Andrew B Peitzman; Timothy R Billiar
Journal:  Ann Surg       Date:  2014-10       Impact factor: 12.969

8.  Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR) gene.

Authors:  E Delabesse; S Aral; P Kamoun; B Varet; A G Turhan
Journal:  Leukemia       Date:  1995-09       Impact factor: 11.528

9.  Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis.

Authors:  John Arcaroli; Eliezer Silva; James P Maloney; Qianbin He; Daiva Svetkauskaite; James R Murphy; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2006-03-09       Impact factor: 21.405

Review 10.  The Y chromosome: a blueprint for men's health?

Authors:  Akhlaq A Maan; James Eales; Artur Akbarov; Joshua Rowland; Xiaoguang Xu; Mark A Jobling; Fadi J Charchar; Maciej Tomaszewski
Journal:  Eur J Hum Genet       Date:  2017-08-30       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.